2012
DOI: 10.1093/infdis/jis290
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin 1 Receptor–Associated Kinase M Impairs Host Defense During Pneumococcal Pneumonia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
48
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 26 publications
(50 citation statements)
references
References 45 publications
2
48
0
Order By: Relevance
“…Similarly, the importance of single immunoglobulin IL-1 receptor-related molecule (SIGIRR), a transmembrane molecule that inhibits TLR signaling, in attenuating the antibacterial response was observed in pneumococcal pneumonia (63), whereas its deficiency proved beneficial for survival and bacterial clearance during P. aeruginosa-induced pneumonia (64), indicating the nonredundant but specific role of this negative regulator in lower respiratory tract infection. Additionally, S. pneumoniae and Klebsiella both exploit host IRAK-M, a regulator that inhibits the activity of IRAKs, to evade pulmonary immune responses (65,66). Additionally, it has recently been shown that M. tuberculosis suppresses Th1 activation via DAP12-mediated induction of IRAK-M, which in turn induces IL-10 expression by antigen-presenting cells (67).…”
Section: Methods Used By Pathogenic Pulmonary Bacteria To Circumvent mentioning
confidence: 99%
“…Similarly, the importance of single immunoglobulin IL-1 receptor-related molecule (SIGIRR), a transmembrane molecule that inhibits TLR signaling, in attenuating the antibacterial response was observed in pneumococcal pneumonia (63), whereas its deficiency proved beneficial for survival and bacterial clearance during P. aeruginosa-induced pneumonia (64), indicating the nonredundant but specific role of this negative regulator in lower respiratory tract infection. Additionally, S. pneumoniae and Klebsiella both exploit host IRAK-M, a regulator that inhibits the activity of IRAKs, to evade pulmonary immune responses (65,66). Additionally, it has recently been shown that M. tuberculosis suppresses Th1 activation via DAP12-mediated induction of IRAK-M, which in turn induces IL-10 expression by antigen-presenting cells (67).…”
Section: Methods Used By Pathogenic Pulmonary Bacteria To Circumvent mentioning
confidence: 99%
“…The models of pneumococcal pneumonia and pneumococcal sepsis have previously been described [23,24]. In short, mice were inoculated intranasally (to induce pneumonia) with 5 × 10 4 CFU of S. pneumoniae (serotype 3; American Type Culture Collection, ATCC 6303, Rockville, Md., USA) or intravenously (to induce primary sepsis) with 5 × 10 5 CFU S. pneumoniae.…”
Section: Methodsmentioning
confidence: 99%
“…In short, mice were inoculated intranasally (to induce pneumonia) with 5 × 10 4 CFU of S. pneumoniae (serotype 3; American Type Culture Collection, ATCC 6303, Rockville, Md., USA) or intravenously (to induce primary sepsis) with 5 × 10 5 CFU S. pneumoniae. Lungs, blood, spleens, and livers were harvested 6, 24, or 48 h postinfection for quantitative bacterial cultures as described (n = 8 or 16 per group at each time point) [23,24]. Neutrophil counts in bronchoalveolar lavage (BAL) fluid were determined as described [25].…”
Section: Methodsmentioning
confidence: 99%
“…IRAK-M is expressed in monocytes/macrophages and in lung epithelial cells and IRAK-M is an important factor to down-regulate host defense in bacterial pneumonia models [1,[14][15][16]19]. In order to study the potential proand anti-inflammatory effects of human WT IRAK-M and the DD mutants on TLR mediated cytokine/chemokine release we stably introduced these proteins in human monocytic cells (THP-1) and in human bronchial lung epithelial cells (H292).…”
Section: Potency Of Irak-m-dd Mutants To Inhibit Tlr Signaling In Macmentioning
confidence: 99%
“…Furthermore, IRAK-M was shown to inhibit the IRAK-2 dependent mRNA stabilization/translation of cytokines and chemokines [13]. Increased host responses caused by lack of IRAK-M are favorable for the clinical outcome in bacterial pneumonia [14][15][16], but also in tumor models [17] and bone marrow transplantation [18] which implies that inhibition of IRAK-M might have therapeutic potential. Different from the other IRAK's, IRAK-M expression is rather restricted to certain cell types such as monocytes/macrophages and lung epithelial cells [1,19] and IRAK-M is up-regulated under inflammatory conditions and associated with LPS tolerance [9,20].…”
Section: Introductionmentioning
confidence: 99%